DeepMed Research

Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

Hydrogel Endovascular Aneurysm Treatment Trial

Not Applicable

Completed

Conditions: Cerebral Aneurysm

Interventions: Device: HydroCoil Embolic System
Device: Control (bare platinum coils)

First Posted Date: 2011-08-02

Last Posted Date: 2019-06-27

Lead Sponsor: Northwestern University

Target Recruit Count: 600

Registration Number: NCT01407952

Locations: 🇺🇸
SUNY Upstate Medical University, Syracuse, New York, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Methodist Hospital Research Institute, Houston, Texas, United States

and more 40 locations

Daily Checklists and Outcome in the Intensive Care Unit

Not Applicable

Completed

Conditions: Critical Illness

Interventions: Other: Electronic checklist
Other: Verbal prompting

First Posted Date: 2011-07-18

Last Posted Date: 2012-12-04

Lead Sponsor: Northwestern University

Target Recruit Count: 451

Registration Number: NCT01396044

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

Effectiveness of Direct-to-Patient Outreach on Colorectal Cancer Screening Within a Low Income and Diverse Population

Not Applicable

Completed

Conditions: Malignant Neoplasm of Large Intestine

Interventions: Other: Care manager outreach

First Posted Date: 2011-06-30

Last Posted Date: 2014-01-06

Lead Sponsor: Northwestern University

Target Recruit Count: 202

Registration Number: NCT01385579

Locations: 🇺🇸
Heartland International Health Center, Chicago, Illinois, United States

rHGH and Intestinal Permeability in Intestinal Failure

Phase 4

Completed

Conditions: Short Bowel Syndrome

Interventions: Drug: Somatropin
Procedure: Seven Day Food Diary
Procedure: Blood Tests (standard of care)
Other: Fasting
Other: Sugar Permeability Test
Other: Urine Collection

First Posted Date: 2011-06-27

Last Posted Date: 2016-02-08

Lead Sponsor: Northwestern University

Target Recruit Count: 15

Registration Number: NCT01380366

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine

Early Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: Diclofenac epolamine patch

First Posted Date: 2011-06-27

Last Posted Date: 2020-02-19

Lead Sponsor: Northwestern University

Target Recruit Count: 30

Registration Number: NCT01380353

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Effect of Platelet Rich Plasma on Photoaged Skin

Phase 1

Active, not recruiting

Conditions: Photoaging

Interventions: Device: Harvest PRP Separation System
Other: Sterile Saline injection

First Posted Date: 2011-06-14

Last Posted Date: 2024-03-18

Lead Sponsor: Northwestern University

Target Recruit Count: 23

Registration Number: NCT01372566

Locations: 🇺🇸
Northwestern University Dermatology, Chicago, Illinois, United States

Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

Phase 2

Conditions: Male Breast Cancer
Stage II Breast Cancer
Estrogen Receptor-negative Breast Cancer
Progesterone Receptor-negative Breast Cancer
Stage IA Breast Cancer
Stage IIIC Breast Cancer
Triple-negative Breast Cancer
HER2-negative Breast Cancer
Stage IB Breast Cancer
Stage IIIA Breast Cancer

Interventions: Drug: eribulin mesylate
Drug: carboplatin
Procedure: biopsy

First Posted Date: 2011-06-14

Last Posted Date: 2019-06-07

Lead Sponsor: Northwestern University

Target Recruit Count: 30

Registration Number: NCT01372579

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia

Phase 2

Active, not recruiting

Conditions: Stage II Chronic Lymphocytic Leukemia
Stage I Chronic Lymphocytic Leukemia
Stage III Chronic Lymphocytic Leukemia
Stage IV Chronic Lymphocytic Leukemia

Interventions: Biological: alemtuzumab
Biological: ofatumumab
Procedure: biopsy

First Posted Date: 2011-05-27

Last Posted Date: 2025-05-23

Lead Sponsor: Northwestern University

Target Recruit Count: 53

Registration Number: NCT01361711

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇸🇪
Karolinska University Hospital Solna, Stockholm, Sweden

Closure Techniques and Scar Appearance

Not Applicable

Withdrawn

Conditions: Wound Closure Techniques

Interventions: Procedure: Subcuticular polyglactin-910 combined with tissue adhesive
Procedure: Tissue Adhesive (Derma-Bond)
Procedure: Running polypropylene closure

First Posted Date: 2011-05-12

Last Posted Date: 2021-12-06

Lead Sponsor: Northwestern University

Registration Number: NCT01352533

E-health Intervention for Cancer Survivors 2.0

Phase 1

Withdrawn

Conditions: Cancer

Interventions: Behavioral: Project Onward website + 8 person social network
Behavioral: Project Onward website + 16 person social network

First Posted Date: 2011-05-06

Last Posted Date: 2014-10-07

Lead Sponsor: Northwestern University

Registration Number: NCT01348997

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy